samsungbiologics-207940-Algorithm Investment Report
0 likes102 views
This document provides performance data for an algorithm from 2014 to 2018 including sales, operating profit, net income, operating rate, net rate, ROE, debt ratio, quick ratio, and reserve ratio on a quarterly and annual basis. It also includes stock price data such as high price, indication price range, current stock price, company score, suggested purchase amount, number of stocks purchased, and investment opinion. Charts are included showing the indication price range and stock price rise probability scores over time for different sectors.
![[Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (Separate) 207940 Date
Period
Gap
(Indication /
stock)
Color
low price 118,370 W 118,370 W ~ 0 W -72 % 202,222 W 2
Low mid 151,806 W 151,806 W ~ 118,370 W -64 % 179,542 W 1
Mid 185,242 W 185,242 W ~ 151,806 W -56 % 156,863 W 1
High mid 218,679 W 218,679 W ~ 185,242 W -47 % 134,183 W 1
Suggested Purchase
Amount 282,513 W
Number of stocks
purchased 1
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 252,115 W 252,115 W~ ~ 218,679 W -39 % 111,503 W 0
2018-05-02
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
416,500 W High price 32.8 Sell 2,000,000 W
Stock price rise
probability score
A Sector 43.8 49.7 50.3 46.8 48.6 46.8
32.8B Sector 50.0 40.4 46.8 46.8 30.8 36.7
Total average 46.9 45.1 34.5 47.9 39.7 41.8
2017.12.01 2018.01.03 2018.01.31 2018.03.05 2018.04.02 2018.04.30
2018.01.31 2018.03.05 2018.04.02 2018.04.30
Total of
increase rate
Total score
A Sector 12 % 1 % -7 % 4 % -4 %
-4 % 42.7B Sector -24 % -116 % 60 % -52 % 16 %
Total average -4 % -31 % 28 % -21 % 5 %
2018.01.03
12%
1% -7%
4% -4%
-24%
-116%
60%
-52%
16%
-4%
-31%
28%
-21%
5%
-150%
-100%
-50%
0%
50%
100%
2018.01.03 2018.01.31 2018.03.05 2018.04.02 2018.04.30
Increase rate of stock price rise
A sector
B sector
Total average
samsungbiologics
44
50 50
47 49 47
50
40
19
47
31
37
47 45
35
48
40 42
0
10
20
30
40
50
60
2017.12.01 2018.01.03 2018.01.31 2018.03.05 2018.04.02 2018.04.30
Stock price rise probability score
A sector
B sector
Total average](https://image.slidesharecdn.com/samsungbiologics-207940-algorithminvestmentreport-180502042429/85/samsungbiologics-207940-Algorithm-Investment-Report-2-320.jpg)
samsungbiologics-207940-Algorithm Investment Report
- 1. Performance Analysis of Algorithm (Separate) 207940 Date Period 3 months 100-m won 2014.12 2015.12 2016.12 Average 2017.03 2017.06 2017.09 2017.12 2018.03 2018.06 IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) Sales 1,051 913 2,946 1,637 1,076 632 1,275 1,663 1,738 2,023 1,162 O-profit -1,195 -2,036 -304 -1,178 34 -85 205 506 419 618 165 N-income -997 19,049 -1,768 5,428 -331 -221 -317 -101 -346 279 -243 O-rate -113.7 -223.0 -10.3 -115.7 3.2 -13.4 16.1 30.4 24.1 30.6 15.1 N-rate -94.9 2,086.4 -60.0 643.8 -30.8 -35.0 -24.9 -6.1 -19.9 13.8 -17.1 ROE -15.8 68.6 -4.3 16.2 -3.3 -2.7 -3.1 -2.5 -3.0 -2.0 -2.8 Debt-ratio 115.0 114.8 84.5 104.8 78.5 76.9 78.1 80.6 81.4 82.1 79.6 Quick-ratio 56.7 3.8 52.4 37.6 40.7 22.3 19.4 18.0 24.5 34.5 26.5 reserve-ratio 478.5 1,910.1 2,365.2 1,584.6 2,345.2 2,331.8 2,312.6 2,306.5 2,294.1 2,281.8 2,312.0 EPS -1,507 28,790 -2,672 8,204 -500 -334 -479 -153 -524 422 -367 BPS 9,532 41,938 61,700 37,723 61,115 60,800 60,322 60,100 59,765 60,364 60,584 Dividends 0 0 0 0 2018-05-02 Major Financial Information Recent Annual Performance Recent quarterly performance Estimate Average Gap (Indication / stock) Color High price ~ -39 % High mid ~ -47 % Mid ~ -56 % Low mid ~ -64 % Low price ~ -72 % Sell 118,370 W 118,370 W 0 W Industrial name of the company The number of All industries Algorithm Industry ranking Total number of listed companies Algorithm company ranking Investment opinion Pharmaceutical 81 34 2,856 1,553 218,679 W 218,679 W 185,242 W 185,242 W 185,242 W 151,806 W Evaluation 252,115 W 252,115 W~ 218,679 W 416,500 W 36.5151,806 W 151,806 W 118,370 W High price Indication price Range Current stock price Company score 118,370원 151,806원 185,242원 218,679원 252,115원 High price 416,500원 -72% -64% -56% -47% -39% -80% -70% -60% -50% -40% -30% -20% -10% 0.% 0W 50,000W 100,000W 150,000W 200,000W 250,000W 300,000W 350,000W 400,000W 450,000W Low price Low mid Mid High mid High price Indication price chart (Separate) Indication price samsungbiologics Gap samsungbiologics
- 2. [Price for scheduled purchasing] Arbitrarily made Algorithm stocks Trading Strategies (Separate) 207940 Date Period Gap (Indication / stock) Color low price 118,370 W 118,370 W ~ 0 W -72 % 202,222 W 2 Low mid 151,806 W 151,806 W ~ 118,370 W -64 % 179,542 W 1 Mid 185,242 W 185,242 W ~ 151,806 W -56 % 156,863 W 1 High mid 218,679 W 218,679 W ~ 185,242 W -47 % 134,183 W 1 Suggested Purchase Amount 282,513 W Number of stocks purchased 1 Indication price Range Buying / Selling Buying / Selling [Stocks] High price 252,115 W 252,115 W~ ~ 218,679 W -39 % 111,503 W 0 2018-05-02 3 months Current stock price Evaluation Stock price rise probability score Investment opinion Prospective purchase amount 416,500 W High price 32.8 Sell 2,000,000 W Stock price rise probability score A Sector 43.8 49.7 50.3 46.8 48.6 46.8 32.8B Sector 50.0 40.4 46.8 46.8 30.8 36.7 Total average 46.9 45.1 34.5 47.9 39.7 41.8 2017.12.01 2018.01.03 2018.01.31 2018.03.05 2018.04.02 2018.04.30 2018.01.31 2018.03.05 2018.04.02 2018.04.30 Total of increase rate Total score A Sector 12 % 1 % -7 % 4 % -4 % -4 % 42.7B Sector -24 % -116 % 60 % -52 % 16 % Total average -4 % -31 % 28 % -21 % 5 % 2018.01.03 12% 1% -7% 4% -4% -24% -116% 60% -52% 16% -4% -31% 28% -21% 5% -150% -100% -50% 0% 50% 100% 2018.01.03 2018.01.31 2018.03.05 2018.04.02 2018.04.30 Increase rate of stock price rise A sector B sector Total average samsungbiologics 44 50 50 47 49 47 50 40 19 47 31 37 47 45 35 48 40 42 0 10 20 30 40 50 60 2017.12.01 2018.01.03 2018.01.31 2018.03.05 2018.04.02 2018.04.30 Stock price rise probability score A sector B sector Total average
- 3. may ded by Compliance notice ① The information provided by The Algorithm Company Analysis Consulting is obtained through reliable data and information and The Algorithm Company Analysis Program (TACAP), but its accuracy or completeness are not guaranteed. Furthermore, it may change over time.Therefore, we are not legally responsible for the results of the data provided by The Algorithm Company Analysis Consulting because of information errors or omissions. ② The Algorithm Company Analysis Consulting and all the information provided on it site are reference materials for investment decisions and the final responsibility of investment is up to users utilizing this information. ③ The Algorithm Company Analysis Consulting and its site do not do anything that violates the related laws such as discretionary transaction. ④ Users can not reallocate and recycle the information provided by The Algorithm Company Analysis Consulting firm let alone the information provided by its Site. ⑤ Be sure to know about application period of this algorithm analysis report in order to improve its accuracy. Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr Homepage : tacac.co.kr Blog : tacac.blog.me SERVICES M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS Request : http://tacac.co.kr/?page_id=1374